If you continue without changing your settings, we’ll assume you’re happy to receive all cookies from the BMA website. Find out more about cookies
When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalised web experience.
Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
These cookies are required
These cookies allow us to know which pages are the most and least popular and see how visitors move around the site. All information we collect is anonymous unless you actively provide personal information to us.
If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
These cookies allow a website to remember choices you make (such as your user name, language or the region you're in) and tailor the website to provide enhanced features and content for you.
For example, they can be used to remember certain log-in details, changes you've made to text size, font and other parts of pages that you can customise. They may also be used to provide services you've asked for such as watching a video or commenting on a blog. These cookies may be used to ensure that all our services and communications are relevant to you. The information these cookies collect cannot track your browsing activity on other websites.
Without these cookies, a website cannot remember choices you've previously made or personalise your browsing experience meaning you would have to reset these for every visit. In addition, some functionality may not be available if this category is switched off.
Our websites sometimes integrate with other companies’ sites. For example, we integrate with social networking sites such as Twitter and Facebook, to make it easier for you to share what you have read. These sites place their own cookies on your browser as a result of us including their icons and ‘like’ or ‘share’ buttons on our sites.
Let’s start with the obvious. Brexit is bad for your health. As the representative organisation of all doctors and medical students in the UK, we have said that already and will continue to highlight the implications Brexit will have on the health service at home. What does Brexit have to do with the falsified medicines directive (FMD)? Actually, not much, but now that I have your attention, let me fill you in on where it came from and what it actually means for general practice.
The FMD (Directive 2011/62/EU) was published on 1 July 2011 in the Official Journal of the European Union and the legislation will become effective on 8th February 2019. It introduces tougher rules to ensure medicines are safe and that the trade in medicines is rigorously controlled. This is being introduced to tackle the counterfeiting high-price medicines that are a threat to public health worldwide. So, the principle of it is a good one.
But, and it is a big but, the legislation will require all prescription medicines for sale to carry a unique and randomised serial number encoded in a 2D-barcode and a visible anti-tampering device. At each stage of the supply chain, the product will be inspected to ensure it has not been tampered with, has not previously been dispensed and that the packaging remains intact. On supplying the medicine to the patient, the unique identifier must be ‘decommissioned’ via a scan from the FMD system, to prevent any duplication of a legitimate identifier for use on a falsified medicine. That’s just a brief overview of the process. All practices (dispensing and non-dispensing) will need to have the infrastructure and processes in place to decommission medicines including for prescription and administration of vaccines.
So, practices will need a lot of hardware and software to comply with the new legislation coming in. GPs will also need more time to incorporate this into their consultations – every time one injects a joint or vaccinates a patient and so on will take that little bit longer. The bigger impact will be for dispensing practices who will see their workload increase much more significantly. And it will cost more in time and resource!
So, what’s Brexit got to do with it? Well, if we crash out of Europe (officially referred to as the no-deal Brexit), it is unlikely that the Directive would come into effect in its current form. Before someone paints that on the side of a bus and starts prophesising how wonderful it would ‘save us from FMD’, it is important to note that the government has been clear that it wants to retain a close working partnership with the EU to ensure patients have access to a safe medicine supply.
Whilst we, the BMA team, has met regularly with the Department of Health and Social Care and others involved in the implementation of the Directive to discuss any adverse implications of its introduction on practices are mitigated, this is something I would urge colleagues to start thinking about. We will continue to argue strongly that the NHS must fund the equipment required and make the necessary IT equipment available to facilitate the Directive so that the impact on the workload of GPs and their employees is kept to a minimum.
So, what is happening? As a dispensing doctor I am not aware that NHS England has provided us with any training, equipment or software to deal with this. Am I meant to fund it out of my own pocket? I would require buying a new dispensing IT system.
If you are one the way to know about how do I access over bing rewards dashboard so you may switch to this platform http://bingrewards.info and can easily have all exact information by which your work will be all easier. So have a visit for once surely you will be having all useful information.
That’s just a brief overview of the process. All practices (dispensing and non-dispensing) will need to have the infrastructure and processes in place to decommission medicines including for prescription and administration of vaccines.
This is a great little post with some valuable tips. I totally agree. I appreciate the abundantly cherished research material people give as a feature of your substance pieces. Richestsoft is one of the top & Best mobile app development company/web development company in India. we offers mobile app development & https://richestsoft.com/ web development company at an affordable prices
Each phase of the inventory network, the item will be assessed to guarantee it has not been messed with, has not recently been administered and that the bundling stays unblemished. On providing the drug to the patient. medium.com/.../homework-promotes-the-understanding-content-material-ecology-and-empowers-youngsters-literacy-2727d2edd4f3